Found: 1
Select item for more details and to access through your institution.
A Phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 3, p. 247, doi. 10.1007/s10637-006-9014-7
- By:
- Publication type:
- Article